Superworth

Equillium EPS EQ

Diluted earnings per share by quarter and over the last twelve months, from 2017.

Last 12 months, to Jun 30, 2026
−$0.20
Latest quarter, Q2 FY26
−$0.04
Fiscal year 2025
−$0.50

Equillium's earnings per share was −$0.20 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.04.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.50n/a
FY2024−$0.23n/a
FY2023−$0.39n/a
FY2022−$1.90n/a
FY2021−$1.35n/a
FY2020−$1.49n/a
FY2019−$1.48n/a
FY2018−$1.06n/a
FY2017n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.04n/a−$0.20
Q1 FY26−$0.06n/a−$0.32
Q4 FY25−$0.04n/a−$0.50
Q3 FY25−$0.06n/a−$0.62
Q2 FY25−$0.16−1700%−$0.56
Q1 FY25−$0.24n/a−$0.39
Q4 FY24−$0.16n/a−$0.23
Q3 FY24$0.00n/a−$0.14
Q2 FY24$0.01n/a−$0.25
Q1 FY24−$0.08n/a−$0.36
Q4 FY23−$0.07−188%−$0.39
Q3 FY23−$0.11n/a−$0.24

Against its peers

Companies in Drug Manufacturers - General nearest Equillium's size, closest first, today.

CompanyEPS, 12 monthsGrowth
EQEquillium−$0.20
LFVNLifevantage$0.40−46% a year
SPROSpero Therapeutics$0.11
ATNMActinium Pharmaceuticals$0.36
NATRNatures Sunshine Products$1.01+36% a year
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
COLLCollegium Pharmaceutical$1.24+19% a year
Peer median$0.65

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Equillium

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.